Muntaj Shaik1, Kruthika-Vinod T P2, Mahesh Kamate3, Vedamurthy A B4. 1. Department of Biotechnology and Microbiology, Karnatak University, Dharwad, Karnataka, India. 2. Department of Neurochemistry, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India. 3. Department of Pediatrics, Jawaharlal Nehru Medical College, KLE University, Belgaum, Karnataka, India. 4. Department of Biotechnology and Microbiology, Karnatak University, Dharwad, Karnataka, India. vedamurthybt@gmail.com.
Abstract
OBJECTIVE: To investigate if expanded newborn screening using tandem mass spectroscopy (TMS) is adequate to detect low excretor phenotype in Indian Glutaric aciduria type I (GA-I) patients. METHODS: Ten GA-I patients were investigated for blood glutaryl carnitine (C5DC) levels on dried blood spot (DBS) by tandem mass spectroscopy and urine glutaric acid (GA) and 3-hydroxyglutaric acid (3-OH-GA) by gas chromatography-mass spectroscopy. The student's T test and Pearson's correlation were applied to draw a relationship between various biochemical parameters. Further confirmation of low excretors by DNA mutation analysis in the glutaryl CoA dehydrogenase (GCDH) gene was performed by polymerase chain reaction and Sangers sequencing. RESULTS: Among 10 GA-I patients, 7 patients were found to have high excretor, and 3 were found to have low excretor phenotype. The low excretors were found to have GCDH gene mutations. The mean C5DC levels in high and low excretors were 2.61 ± 2.02 μmol/L and 2.31 ± 1.00 μmol/L, respectively. In high excretors, C5DC levels correlated with GA (r = 0.95). In low excretors, C5DC levels correlated with 3-OH-GA (r = 0.99). No significant difference was found between C5DC levels of high and low excretors (p = 0.82). CONCLUSIONS: The MS/MS, C5DC screening is a sensitive technique and detected 10 GA-I patients. Irrespective of the urine organic acid levels, Indian GA-I patients including low excretors seem to have a significantly elevated C5DC level and well above the stipulated cut-off values and therefore, expanded newborn screening is probably adequate to diagnose them.
OBJECTIVE: To investigate if expanded newborn screening using tandem mass spectroscopy (TMS) is adequate to detect low excretor phenotype in Indian Glutaric aciduria type I (GA-I) patients. METHODS: Ten GA-I patients were investigated for blood glutaryl carnitine (C5DC) levels on dried blood spot (DBS) by tandem mass spectroscopy and urine glutaric acid (GA) and 3-hydroxyglutaric acid (3-OH-GA) by gas chromatography-mass spectroscopy. The student's T test and Pearson's correlation were applied to draw a relationship between various biochemical parameters. Further confirmation of low excretors by DNA mutation analysis in the glutaryl CoA dehydrogenase (GCDH) gene was performed by polymerase chain reaction and Sangers sequencing. RESULTS: Among 10 GA-I patients, 7 patients were found to have high excretor, and 3 were found to have low excretor phenotype. The low excretors were found to have GCDH gene mutations. The mean C5DC levels in high and low excretors were 2.61 ± 2.02 μmol/L and 2.31 ± 1.00 μmol/L, respectively. In high excretors, C5DC levels correlated with GA (r = 0.95). In low excretors, C5DC levels correlated with 3-OH-GA (r = 0.99). No significant difference was found between C5DC levels of high and low excretors (p = 0.82). CONCLUSIONS: The MS/MS, C5DC screening is a sensitive technique and detected 10 GA-I patients. Irrespective of the urine organic acid levels, Indian GA-I patients including low excretors seem to have a significantly elevated C5DC level and well above the stipulated cut-off values and therefore, expanded newborn screening is probably adequate to diagnose them.
Entities:
Keywords:
Glutaric acid; Glutaric aciduria type I; Glutaryl carnitine; Newborn screening; Tandem mass spectroscopy
Authors: Jana Heringer; S P Nikolas Boy; Regina Ensenauer; Birgit Assmann; Johannes Zschocke; Inga Harting; Thomas Lücke; Esther M Maier; Chris Mühlhausen; Gisela Haege; Georg F Hoffmann; Peter Burgard; Stefan Kölker Journal: Ann Neurol Date: 2010-11 Impact factor: 10.422
Authors: M J Fraidakis; C Liadinioti; L Stefanis; A Dinopoulos; R Pons; M Papathanassiou; J Garcia-Villoria; A Ribes Journal: JIMD Rep Date: 2014-09-26
Authors: Nikolas Boy; Chris Mühlhausen; Esther M Maier; Jana Heringer; Birgit Assmann; Peter Burgard; Marjorie Dixon; Sandra Fleissner; Cheryl R Greenberg; Inga Harting; Georg F Hoffmann; Daniela Karall; David M Koeller; Michael B Krawinkel; Jürgen G Okun; Thomas Opladen; Roland Posset; Katja Sahm; Johannes Zschocke; Stefan Kölker Journal: J Inherit Metab Dis Date: 2016-11-16 Impact factor: 4.982
Authors: C Busquets; B Merinero; E Christensen; J L Gelpí; J Campistol; M Pineda; E Fernández-Alvarez; J M Prats; A Sans; R Arteaga; M Martí; J Campos; M Martínez-Pardo; A Martínez-Bermejo; M L Ruiz-Falcó; J Vaquerizo; M Orozco; M Ugarte; M J Coll; A Ribes Journal: Pediatr Res Date: 2000-09 Impact factor: 3.756
Authors: Ma Luz Couce; Olalla López-Suárez; Ma Dolores Bóveda; Daisy E Castiñeiras; José A Cocho; Judith García-Villoria; Manuel Castro-Gago; José Ma Fraga; Antonia Ribes Journal: Eur J Paediatr Neurol Date: 2013-02-05 Impact factor: 3.140